Local irradiation of patient-derived tumors in immunodeficient mice

STAR Protoc. 2023 Mar 17;4(1):102098. doi: 10.1016/j.xpro.2023.102098. Epub 2023 Feb 7.

Abstract

Severe combined immunodeficient mice are typically used for xenografting experiments and show reliable tumor engraftment; however, their Prkdscid mutation renders them highly sensitive to irradiation. Here, we describe a protocol that allows safe local irradiation of tumor xenografts in immunodeficient mice. We detail the steps for the establishment and handling of patient-derived cancer cultures, subcutaneous injection of cancer cells on the mouse hind limb, localized irradiation in mice, tumor monitoring, and tumor characterization via histological and immunohistochemical assessment. For complete details on the use and execution of this protocol, please refer to Dings et al. (2022).1.

Keywords: Cancer; Cell Culture; Health Sciences; Microscopy; Model Organisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Mice
  • Mice, SCID
  • Neoplasms* / radiotherapy